Navigation Links
UCLA researchers develop new PET scanning probe that will allowing monitoring of the immune system

Researchers at UCLA's Jonsson Comprehensive Cancer Center have modified a common chemotherapy drug to create a new probe for Positron Emission Tomography (PET), an advance that will allow them to model and measure the immune system in action and monitor response to new therapies.

The discovery, published June 8, 2008 in the early online edition of the journal Nature Medicine, enables scientists to monitor the immune system at the whole body level in 3D as it tries to fight some cancers or when it goes awry as it does in autoimmune diseases.

Researchers created the small molecule, called FAC, by slightly altering the molecular structure of one of the most commonly used chemotherapy drugs, gemcitabine. They then added a radiolabel so the cells that take in the probe can be seen during PET scanning.

The probe is based on a fundamental cell biochemical pathway called the DNA Salvage Pathway, which acts as a sort of recycling mechanism that helps with DNA replication and repair. All cells use this biochemical pathway to different degrees. But in lymphocytes and macrophages, the cells of the immune system that initiate immune response, the pathway is activated at very high levels. Because of that, the probe accumulates at high levels in those cells, said Dr. Owen Witte, a researcher at UCLA's Jonsson Cancer Center, a Howard Hughes Medical Institute investigator and senior author of the study.

"This is not a cure or a new treatment, but it will help us to more effectively model and measure the immune system," said Witte, who also serves as director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA. "Monitoring immune function using molecular imaging could significantly impact the diagnosis and treatment evaluation of immunological disorders, as well as evaluating whether certain therapies are effective."

Because the probe is labeled with positron emitting particles, cells that take it in glow "hot" under PET scanning, which operates as a molecular camera that enables visualization of biological processes in living organisms. The work, done in animal models, will be further evaluated in subsequent studies. Eventually, Witte said, researchers hope to be able to monitor the immune systems of patients with FAC and other PET probes.

"This measurement is not invasive - it involves a simple injection of the probe," Witte said. "We could do repetitive scans in a single week to monitor immune response."

Using conventional methods, oncologists are forced to wait weeks and often months to determine whether a patient is responding to a therapy. CT and MRI scans are taken before and during treatment and the size of the tumor is measured to determine response if the tumor is shrinking, the patient is responding. However, patients that don't respond are exposed to potentially toxic therapies for longer than necessary. If the new PET probe can monitor immune response and response to treatment much more quickly within a week or two patients would be spared from therapies that aren't working.

One frustrating aspect for many cancer researchers is understanding the role of the immune response in fighting or, in some cases, possibly stimulating tumor growth, said Dr. Kevin Shannon, the Auerback Distinguished Professor of Molecular Oncology at the University of California, San Francisco.

"Dynamic probes like the one developed by UCLA scientists will allow researchers to learn more about the role of the immune response in cancer, how current treatments affect immune cells, and will allow them to quantitatively monitor responses to new modalities such as tumor vaccines," Shannon said. "Probes of this type may also help oncologists more rapidly identify tumors that will respond to certain drugs so treatments can be made more patient-specific."

Witte said the type of multidisciplinary research that led to development of the probe is uniquely suited to UCLA's collaborative strengths. Researchers from the cancer center, the Broad stem cell center and the Crump Institute for Molecular Imaging took part in the study. The PET scanner was invented by UCLA's Michael Phelps, also a co-author on this study.

The work by Witte and his colleagues was prompted by the desire to add to a short list of probes now used in PET scanning and to develop new probes that monitor different molecular functions than the current probes.

"What we wanted to do was to develop new ways to look inside a living organism and gather as much information as we can about the immune system," said Caius Radu, an assistant professor of molecular and medical pharmacology, a Jonsson Cancer Center researcher and the first author of the study. "We wanted to know how cells move from one site in the body to another and find a way to trace them to tumors."

In previous studies, Witte and other UCLA researchers were able to track the immune system as it recognized and responded to cancer. But in those studies, the cells had to be modified with "reporter" genes that sequestered a specifically designed PET probe that allowed scientists to monitor them. The new probe doesn't require modified cells, making it easier and less expensive to use and giving it far broader applications than existing probes. In addition to modeling and measuring the immune system, those applications include stratifying different types of cancers and their response to therapy, defining the level of immune response in both normal and pathological situations and helping to determine whether new drugs prompt an immune response to cancer and other diseases.

"This probe will tell us things about the immune system that existing probes can't," said Radu, who also is a member of the Crump Institute for Molecular Imaging.


Contact: Kim Irwin
University of California - Los Angeles

Related biology news :

1. Researchers observe spontaneous ratcheting of single ribosome molecules
2. At Boston symposium, NARSAD researchers report on genes and family traits
3. Fruits, vegetables and teas may protect smokers from lung cancer, UCLA researchers report
4. 2 University of Illinois researchers named HHMI investigators
5. New family of gecko discovered by researchers from the U of Minnesota and Villanova University
6. Montana State University researchers map iron transport protein
7. Gene mutations in mice mimic human-like sleep disorder, UT Southwestern researchers find
8. UF researchers develop improved gene therapy agent
9. Researchers document rapid, dramatic reverse evolution in the threespine stickleback fish
10. Stowers Institute researchers identify gene linked to vertebral defects in patient populations
11. Researchers discover architecture for fundamental processes of life
Post Your Comments:
(Date:10/12/2015)... Research and Markets ( ) has announced the ... Market Shares, Strategies, and Forecasts, Worldwide, 2015-2021" to ... --> The study is designed to give a ... a selection from the mountains of data available of ... made by the most senior analysts. Commentary on every ...
(Date:10/12/2015)... , October 12, 2015 NXTD ) ... the growing mobile commerce market, reports on the recent SNS ... . --> NXTD ) ("NXT-ID" or the ... commerce market, reports on the recent SNS Future in Review ... --> NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ...
(Date:10/9/2015)... 2015 ... "Samsung Galaxy S6 Fingerprint Sensor - ... offering. --> ) has ... Galaxy S6 Fingerprint Sensor - Reverse Costing ... --> Research and Markets ( ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... ALBANY, New York , October 13, 2015 ... Share, Growth, Trends, and Forecast 2015 - 2023 " ... bn in 2014 and is anticipated to reach US$7.59 bn by ... from 2015 to 2023. --> " Microbiology Culture ... 2015 - 2023 " , the global microbiology ...
(Date:10/13/2015)... TapImmune, Inc. (TPIV), a ... peptide and gene-based immunotherapeutics and vaccines for the treatment ... presenting company at the Dawson James Small Cap ... Jupiter, Florida on October 15, ... clinical-stage immunotherapy company specializing in the development of innovative ...
(Date:10/13/2015)... Charlotte, NC (PRWEB) , ... October 13, 2015 ... ... high intensity focused ultrasound (HIFU) technologies, announced today that it received de novo ... 450 in the U.S. for the ablation of prostate tissue. Sonablate® is ...
(Date:10/12/2015)... (PRWEB) , ... October 12, 2015 , ... Spirax Sarco, ... the release of the CSM-C 600 compact clean steam generator . This ... that meets the requirements of HTM2031, HTM2010, and EN285 standards. The CMS-C 600 ...
Breaking Biology Technology: